A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging.

BACKGROUND AND PURPOSE Normal sized pelvic lymph nodes are not easily identifiable on conventional imaging, but can be visualised with contrast-enhanced magnetic resonance imaging (MRI) using intravenous ultra-small particles of iron-oxide (USPIO). We have previously reported pelvic node clinical target volume (CTV) delineation guidelines for use with conventional imaging, derived from nodal mapping studies using USPIO. This study aims to verify these guidelines using an independent observer in a further patient cohort. MATERIALS AND METHODS Ten patients with gynaecological cancer underwent MRI with and without intravenous USPIO. The guidelines were used to outline a pelvic node CTV on pre-contrast T2-weighted images. On post-contrast T2-weighted images the pelvic nodes were identified and outlined. The pre- and post-contrast images were co-registered and CTV examined for node coverage. RESULTS By applying the guidelines, full coverage of 737 of 741 node outlines was achieved (>99%). Four nodes were not completely encompassed, two anterior external iliac nodes and two lateral external iliac nodes. CONCLUSIONS MRI with USPIO contrast enabled the production of guidelines for localising a pelvic node CTV with conventional imaging. Application of these guidelines to a further patient cohort resulted in coverage of 99.5% node outlines demonstrating the reliability of this technique.

[1]  John C Roeske,et al.  Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.

[2]  T. Cheung,et al.  Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. , 2000, AJR. American journal of roentgenology.

[3]  J. Buatti,et al.  Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer? , 2003, International journal of radiation oncology, biology, physics.

[4]  J. Roeske,et al.  Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. , 2000, International journal of radiation oncology, biology, physics.

[5]  Patrick M M Bossuyt,et al.  Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. , 2003, Gynecologic oncology.

[6]  J A Koutcher,et al.  AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. , 1994, Radiology.

[7]  N. Sakuragi,et al.  Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy , 1999, Cancer.

[8]  N. deSouza,et al.  Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. , 2001, AJR. American journal of roentgenology.

[9]  S. Kalnicki,et al.  Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. , 2003, Gynecologic oncology.

[10]  G. Marchal,et al.  Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) – results of a phase-III multicenter clinical trial , 2002, European Radiology.

[11]  M. Harisinghani,et al.  Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J Williamson,et al.  Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. , 1999, International journal of radiation oncology, biology, physics.

[13]  G. Scambia,et al.  Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. , 1996, Gynecologic oncology.

[14]  John C Roeske,et al.  Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. , 2003, International journal of radiation oncology, biology, physics.

[15]  M R Segal,et al.  Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. , 1997, JAMA.

[16]  D P Dearnaley,et al.  Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. , 2000, International journal of radiation oncology, biology, physics.

[17]  A. Darzi,et al.  Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. , 2006, The Lancet. Oncology.

[18]  K. Eichler,et al.  Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. , 2002, Radiology.

[19]  Chun-Chieh Wang,et al.  Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[20]  K. Chao,et al.  Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.

[21]  B. Marincek,et al.  USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results , 2004, European Radiology.

[22]  D Low,et al.  Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. , 2001, International journal of radiation oncology, biology, physics.

[23]  R. Reznek,et al.  Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[24]  A. Rockall,et al.  An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[25]  D. Koh,et al.  Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. , 2004, Radiology.

[26]  M. Taupitz,et al.  Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. , 2004, Radiology.

[27]  Ralph Weissleder,et al.  Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. , 2004, International journal of radiation oncology, biology, physics.